Liver biomarkers of silymarin milk thistle on paracetamol induced liver toxicity in adult albino rats (Rattus norvegicus)
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20250474Keywords:
Hepato-restorative, Liver biomarkers, Paracetamol hepato-toxicity, Silymarin milk thistleAbstract
Background: Paracetamol is the most common analgesic that is readily available with or without prescription over the counter and its toxicity is due to misuse or overdose associated with liver damage. Silymarin milk thistle is an edible herb believed to have antioxidant, scavenging and regulation of glutathione contents within the cell. Aim of the study was to determine the effects of different doses of silymarin milk thistle on liver biomarkers of paracetamol induced liver toxicity among albino rats.
Methods: Twenty-four adult albino rats were randomly grouped into four groups each group consisting of six animals. Paracetamol-only group given high dose paracetamol-750 mg/kbwt and control group received water and food only. The experimental group, were divided into three subgroups with all receiving high dose paracetamol for five days and thereafter given varying doses of silymarin milk thistle. SIL-G1 given 200 mg/kbwt of silymarin milk thistle, SIL-G2 given 400 mg/kbwt of silymarin milk thistle and SIL-G3 was given 600 mg/kbwt of silymarin milk thistle. All the animals were fed with standard rodent foods and water ad libitum. After completion of 24 hours of the last drug administration, they were humanely sacrificed, serum biochemical analysis of liver biomarkers (ALP, ALT and AST) was determined.
Results: High dose of paracetamol induced liver toxicity. Upon administration of high dose of silymarin milk thistle, there was restoration of ALP, AST and ALP of all these biomarkers in relation to the control group.
Conclusions: These findings showed that high dose (600 mg/kbwt) of silymarin milk thistle was found to have restorative effects and normalized liver biomarkers of ALP, AST and ALT.
Metrics
References
Mallet C, Desmeules J, Pegahi R, Eschalier A. An updated review on the metabolite (AM404)-mediated central mechanism of action of paracetamol (acetaminophen): experimental evidence and potential clinical impact. J Pain Res. 2023;2:1081-94. DOI: https://doi.org/10.2147/JPR.S393809
Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, application and safety concern. Acta Poloniae Pharmaceutica. 2014;71(1):11-23
Tittarelli R, Pellegrini M, Scarpellini MG, Marinelli E, Bruti V, Di Luca NM, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017;21(1): 95-101.
Kurtovic J and Riordan SM. Paracetamol-induced hepatotoxicity at recommended dosage. J Int Med. 2003;253(2):240-3. DOI: https://doi.org/10.1046/j.1365-2796.2003.01097.x
Fukuda M, Hirayu N, Nabeta M, Takasu O. Acute Liver Failure After Administration of Acetaminophen at the Recommended Daily Dose in an Adult: A Case Report. Cureus. 2023 Sep;15(9):567. DOI: https://doi.org/10.7759/cureus.45735
Khazaei R, Seidavi A, Bouyeh M. A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals. Veterinary Medicine and Science. 2022;8(1):289-301. DOI: https://doi.org/10.1002/vms3.641
Saller R, Melzer J, Reichling J, Brignoli R, Meier R. An updated systematic review of the pharmacology of silymarin. Forschende Komplementärmedizin/Res in Complemen Med. 2007;14(2):70-80. DOI: https://doi.org/10.1159/000100581
Nancy Vargas-Mendoza, Eduardo Madrigal-Santillan, Angel Morales-Gonzalez and Jaime. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6(3):144. DOI: https://doi.org/10.4254/wjh.v6.i3.144
Peter F Surai. Silymarin as a natural antioxidant: an overview of the current evidence and perspectives. Antioxidants. 2015;4(1):204-47. DOI: https://doi.org/10.3390/antiox4010204
Bradly P Jacobs, Cathy Dennehy, Gilbert Ramirez, Jodi Sapp and Valerie A Lawrence. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. The Am J Med. 2002;113(6):506-15. DOI: https://doi.org/10.1016/S0002-9343(02)01244-5
Avelar CR, Pereira EM, Costa PRF. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World J Gastroenterol. 2017;23(27):5004. DOI: https://doi.org/10.3748/wjg.v23.i27.5004
Hajagha MA, Ziaei A, Rafiei R. The efficacy of silymarin in decreasing transaminase activities in non-alcoholic fatty liver disease: A randomized controlled clinical trial. Hepatitis Month. 2008;3(8):191-5.
David S, Hamilton JP. Drug-induced liver injury. US Gastroenterol & Hepatol Review. 2010;6:73.
Arifin MZ. Sample size calculation in animal studies using resource equation approach Malaysian. J Med Sci. 2017;24(5):101-5. DOI: https://doi.org/10.21315/mjms2017.24.5.11
Chidiac AS, Buckley NA, Noghrehchi F. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures and estimates of burden of disease. Expert Opinion on Drug Metabol & Toxicol. 2023;19(5):297-317. DOI: https://doi.org/10.1080/17425255.2023.2223959
Asrani SK, Devarbhavi H, Eaton J. S. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-71. DOI: https://doi.org/10.1016/j.jhep.2018.09.014
Fontana RJ. Acute liver failure including acetaminophen overdose. Medical Clinics of North America. 2008;92(4):761-94. DOI: https://doi.org/10.1016/j.mcna.2008.03.005
Agrawal S, Khazaeni B. Acetaminophen toxicity. 2017.
Puri P, Lee WM, Fontana RJ, Kim NK, Durkalski V, McGuire BM, Liou I, Pezzia C, Stravitz RT, Acute Liver Failure Study Group. Alcohol consumption is associated with the severity and outcome of acute liver injury/failure. Liver International. 2020;40(2):360-7. DOI: https://doi.org/10.1111/liv.14327
Chilvery S, Yelne A, Khurana A, Saifi MA, Bansod S, Anchi P, et al. Acetaminophen induced hepatotoxicity: An overview of the promising protective effects of natural products and herbal formulations. Phytomedicine. 2023;108:154510. DOI: https://doi.org/10.1016/j.phymed.2022.154510
Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY, Shyu JC, et al. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J Viral Hepat. 2008;15(7):508-14. DOI: https://doi.org/10.1111/j.1365-2893.2008.00971.x
Freitag AF, Cardia GF, da Rocha BA. Hepatoprotective effect of silymarin (silybum marianum) on hepatotoxicity induced acetaminophen in spontaneously hypertensive rats. Evid Based Complement Alternat Med. 2015;2015:538317. DOI: https://doi.org/10.1155/2015/538317
Ahmed AF, Mahmoud MF, Ouf MA, Abd El-Fathaah E. Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats. Annals of hepatology. 2016;10(2):207-15. DOI: https://doi.org/10.1016/S1665-2681(19)31570-4
Palanivel MG, Rajkapoor B, Kumar RS, Einstein JW. Hepatoprotective and antioxidant effect of Pisonia aculeata L. against CCl4-induced hepatic damage in rats. Scientia pharmaceutica. 2008;76(2):203-16. DOI: https://doi.org/10.3797/scipharm.0803-16
Saeed M, Babazadeh D, Arif M, Arain MA, Bhutto ZA, Shar AH, et al. Silymarin: a potent hepatoprotective agent in poultry industry. World's Poultry Sci J. 2017;73(3):483-92. DOI: https://doi.org/10.1017/S0043933917000538
Senthilkumar R, Chandran R, Parimelazhagan T. Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats. Saudi J Biol Sci. 2014;21(5):409-16. DOI: https://doi.org/10.1016/j.sjbs.2014.04.001
Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Alternative Medicine Rev. 2005;10(3):89.
Hamza RZ, Al-Harbi MS. Amelioration of paracetamol hepatotoxicity and oxidative stress on mice liver with silymarin and Nigella sativa extract supplements. Asian Pacific J Trop Biomed. 2015;5(7):521-31. DOI: https://doi.org/10.1016/j.apjtb.2015.03.011
Downloads
Published
How to Cite
Issue
Section
